secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aridis Pharmaceuticals, Inc. (—)
CIK:        0001614067
Form:       8-K
Filed at:   2023-12-18T23:59:59+00:00
Accession:  0001493152-23-045212
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aridis Pharmaceuticals amends bylaws to set stockholder meeting quorum at 33.33%
--------------------------------------------------------------------------------

- Board approved quorum reduction to one-third (33.33%) of shares entitled to vote.
- Amendment effective December 16, 2023; intended to facilitate holding stockholder meetings.
- Full text of amendment filed as Exhibit 3.1 to the Form 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1614067/000149315223045212/0001493152-23-045212-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1614067/000149315223045212/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-045212

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer